Novo Nordisk Posts Rise In Profit

reported a jump in its profit for the three months to the end of March. Novo Nordisk's quarterly net profit climbed to 9.88 billion Danish kroner ($1.47 billion), versus a year-ago profit of DKK6.46 billion kroner. Its revenue gained 24 percent to DKK25.20 billion, compared to DKK20.34 billion. Its gross margin widened to 84.6 percent in the first quarter, versus 83.0 percent in the year-ago period. For 2015, Novo Nordisk projects sales in local currencies to rise 7 percent to 9 percent. Novo Nordisk shares fell 0.22 percent to $55.47 in pre-market trading.